Key result
Molecular autopsy identifies a pathogenic or potentially pathogenic genetic alteration in nearly 30% of sudden arrhythmic death cases in children under 16 years of age.
Why the study?
Despite increases in post-mortem genetic diagnosis, many families lack a conclusive genetic cause after sudden death, with ongoing challenges in genotype-phenotype associations and classifying variants of uncertain significance.
Molecular autopsy can identify a pathogenic genetic alteration in nearly 30% of pediatric sudden arrhythmic death cases, though challenges remain in variant classification and genotype-phenotype associations.
May support cascade family screening after pediatric SADS; leaves open routine molecular autopsy given Level 5 review evidence.
Sudden death is a rare event in the pediatric population but with a social shock due to its presentation as the first symptom in previously healthy children. Comprehensive autopsy in pediatric cases identify an inconclusive cause in 40-50% of cases. In such cases, a diagnosis of sudden arrhythmic death syndrome is suggested as the main potential cause of death. Molecular autopsy identifies nearly 30% of cases under 16 years of age carrying a pathogenic/potentially pathogenic alteration in genes associated with any inherited arrhythmogenic disease. In the last few years, despite the increasing rate of post-mortem genetic diagnosis, many families still remain without a conclusive genetic cause of the unexpected death. Current challenges in genetic diagnosis are the establishment of a correct genotype-phenotype association between genes and inherited arrhythmogenic disease, as well as the classification of variants of uncertain significance. In this review, we provide an update on the state of the art in the genetic diagnosis of inherited arrhythmogenic disease in the pediatric population. We focus on emerging publications on gene curation for genotype-phenotype associations, cases of genetic overlap and advances in the classification of variants of uncertain significance. Our goal is to facilitate the translation of genetic diagnosis to the clinical area, helping risk stratification, treatment and the genetic counselling of families.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a review in Inherited arrhythmogenic disease. Molecular autopsy and genetic diagnosis was evaluated. Molecular autopsy identifies a pathogenic or potentially pathogenic genetic alteration in nearly 30% of sudden arrhythmic death cases in children under 16 years of age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: